naringenin has been researched along with Dyslipidemias in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allister, EM; Edwards, JY; Hegele, RA; Huff, MW; Markle, JM; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Telford, DE | 1 |
Assini, JM; Huff, MW; Mulvihill, EE | 1 |
Elisaf, MS; Kostapanos, MS; Maltezos, E; Papanas, N; Rizos, EC | 1 |
2 review(s) available for naringenin and Dyslipidemias
Article | Year |
---|---|
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias.
Topics: Animals; Apolipoproteins B; Benzamides; Benzimidazoles; Carrier Proteins; Dyslipidemias; Flavanones; Humans; Hypolipidemic Agents; Malonates; Methaqualone | 2013 |
1 other study(ies) available for naringenin and Dyslipidemias
Article | Year |
---|---|
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
Topics: Alanine Transaminase; Animals; Anti-Ulcer Agents; Apolipoproteins B; Aspartate Aminotransferases; Blood Glucose; Body Weight; Dietary Fats; DNA, Mitochondrial; Dyslipidemias; Energy Intake; Estrogen Antagonists; Flavanones; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipoproteins, VLDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Triglycerides | 2009 |